Browsing Tag
obesity
46 posts
Can you laugh your way to weight loss? The Science behind laughter therapy
Laughter has long been praised as the best medicine, but recent studies suggest it may also play a…
January 18, 2025
Why BioAge Labs’ promising obesity drug trial of azelaprag came to an abrupt halt
BioAge Labs, a clinical-stage biopharmaceutical company focused on metabolic disease research, has announced the discontinuation of its STRIDES…
December 7, 2024
Transform your body with these proven weight loss strategies!
Weight loss is a common challenge faced by people around the globe. Achieving and maintaining a healthy weight…
July 20, 2024
Zealand Pharma announces promising results from dapiglutide trial for obesity treatment
Zealand Pharma A/S (Nasdaq: ZEAL), a pioneer in peptide-based drug development, has shared topline results from its DREAM…
May 25, 2024
Lilly’s Zepbound marks remarkable weight loss milestone in SURMOUNT-4 study
In a significant development in the field of obesity treatment, Lilly’s Zepbound (tirzepatide) has shown remarkable results in…
December 13, 2023
Roche to acquire Carmot Therapeutics to expand obesity treatment portfolio
Roche announced its definitive agreement to acquire Carmot Therapeutics, Inc., based in Berkeley, California, for an upfront purchase…
December 6, 2023
Pfizer’s danuglipron shows promising results in Phase 2b obesity trial
Pfizer Inc. (NYSE: PFE) has announced encouraging topline data from its Phase 2b clinical trial (NCT04707313) investigating danuglipron,…
December 3, 2023
Lilly bags Zepbound FDA approval for obesity treatment
The U.S. Food and Drug Administration has granted approval to Eli Lilly’s Zepbound (tirzepatide) injection, making it the…
November 9, 2023
Biocon and Juno Pharmaceuticals ink game-changing diabetes drug deal
Biocon Limited, the innovation-driven global biopharmaceutical frontrunner, has made headlines by sealing a significant partnership agreement with Juno…
October 7, 2023
Novo Nordisk acquires Embark Biotech and enters R&D collaboration to advance obesity treatments
Novo Nordisk, a global leader in healthcare, has acquired Embark Biotech, including its lead metabolic program, in a…
August 30, 2023